Pink Sheet Podcast: Sarepta DMD Gene Therapy Issues, New COVID-19 Vaccine Schedule, Medicare Price Negotiation
Executive Summary
Pink Sheet reporters and editors discuss questions about Sarepta’s Duchenne muscular dystrophy gene therapy candidate, the US FDA’s efforts to simplify the COVID-19 vaccine schedule, and industry’s ideas for Medicare price negotiation system changes.